What is the clinical evidence from this study?

Study design: Observational. Population: Liposarcoma (n=53). Intervention: Array-CGH profiling vs. Conventional karyotyping. Primary outcome: Detection of copy number aberrations (CNAs).

What does this research mean for the field?

High-resolution array-CGH genomic profiling reveals distinct copy number aberration profiles across well-differentiated, dedifferentiated, and myxoid liposarcomas that facilitate their differential diagnosis. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

March 16, 2017Molecular CytogeneticsOpen Access

Application of high-resolution genomic profiling in the differential diagnosis of liposarcoma

View Full Paper

Ask AI

Bookmark

Key result

Array-CGH profiling identifies copy number aberrations in ~97% of liposarcomas, facilitating differential subtype diagnosis.

n=53

Why the study?

Does array-based comparative genomic hybridization (array-CGH) facilitate the differential diagnosis of liposarcoma subtypes?

Population

66 liposarcomas, including well-differentiated (WDLPS), dedifferentiated (DDLPS) and myxoid (MLPS) subtypes

Design

Other

Authors

MKMagdalena KoczkowskaGdańsk Medical University BLBeata S. Lipska‐ZiętkiewiczGTx (United States)MIMariola IliszkoUniversity Clinical Centre

Discussion

Member takes

Implication

Array-CGH may aid liposarcoma subtyping; leaves open prospective validation before clinical adoption.

Study Design

Type

Observational (n=53)

Multicenter

Structured PICO

Does array-based comparative genomic hybridization (array-CGH) facilitate the differential diagnosis of liposarcoma subtypes?

Population

53 patients with liposarcoma (yielding 69 fresh-frozen tumor samples) underwent array-CGH profiling to identify subtype-specific genomic aberrations.

Exposure

Array-based comparative genomic hybridization (array-CGH)

Outcome

Genomic profiles (Copy number aberrations)surrogate

Array-CGH delineates distinct genomic profiles for liposarcoma subtypes, facilitating their differential diagnosis.

Limitations

Array-CGH does not detect balanced translocations, inversions, or point mutations
Fresh frozen material is preferred over FFPE specimens, which often increase experimental noise
Tumor DNA may be contaminated with DNA from non-neoplastic cells
Constitutional normal DNA from the patient was not always available as a reference

Cite This Study

Koczkowska et al. (2017) conducted an observational in Liposarcoma (n=53). Array-CGH profiling vs. Conventional karyotyping was evaluated on Detection of copy number aberrations (CNAs). Array-CGH profiling identified copy number aberrations in 97% of liposarcoma tumors, delineating characteristic genomic profiles that facilitate the differential diagnosis of liposarcoma subtypes.

synapsesocial.com/papers/6aa8d5449288fef1ce2774da https://doi.org/10.1186/s13039-017-0309-5

View Full Paper

Ask AI

Bookmark

Application of high-resolution genomic profiling in the differential diagnosis of liposarcoma

Discussion

Member takes

Implication

Study Design

Structured PICO

Limitations

Cite This Study

Application of high-resolution genomic profiling in the differential diagnosis of liposarcoma

Discussion

Member takes

Implication

Study Design

Structured PICO

Limitations

Cite This Study

Also Consider

Also Consider